Sarah Chiang
synapse.mskcc.org
0000-0001-9698-0936
Memorial Sloan Kettering Cancer Center
26 papers found
Refreshing results…
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer
Supplementary Figure S11 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S12 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S1 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Table S2 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Data from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S8 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S5 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S3 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S10 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S6 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S4 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S7 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S2 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Figure S9 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Supplementary Table S1 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas
Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
Missing publications? Search for publications with a matching author name.